{"id":"https://openalex.org/W64455787","doi":null,"title":"Bioavailability study of two carbamazepine containing sustained release formulations after multiple oral dose administration.","display_name":"Bioavailability study of two carbamazepine containing sustained release formulations after multiple oral dose administration.","publication_year":1998,"publication_date":"1998-12-01","ids":{"openalex":"https://openalex.org/W64455787","mag":"64455787","pmid":"https://pubmed.ncbi.nlm.nih.gov/9893926"},"language":"en","primary_location":{"id":"pmid:9893926","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9893926","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080477869","display_name":"Martina Wangemann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4309215","display_name":"Desitin Arzneimittel (Germany)","ror":"https://ror.org/02axfcj91","country_code":"DE","type":"company","lineage":["https://openalex.org/I4309215"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M Wangemann","raw_affiliation_strings":["Desitin Arzneimittel GmbH, Medizinische Forschung, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Desitin Arzneimittel GmbH, Medizinische Forschung, Hamburg, Germany","institution_ids":["https://openalex.org/I4309215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008865536","display_name":"Angelika Retzow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Retzow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"G Evers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Evers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038852907","display_name":"Dago Mazur","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Mazur","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026056908","display_name":"Barbara S. Schug","orcid":"https://orcid.org/0000-0001-8137-6509","observed_orcids":["https://orcid.org/0000-0001-8137-6509"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Schug","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5064054320","display_name":"H Blume","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Blume","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.00790861,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":"12","first_page":"1131","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.7724999785423279,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.7724999785423279,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.056299999356269836,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.041099999099969864,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":1.0},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.8450000286102295},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.9879999756813049},{"id":"https://openalex.org/keywords/multiple-oral-dosing","display_name":"multiple oral dosing","score":0.6650000214576721},{"id":"https://openalex.org/keywords/carbamazepine-10-11-epoxide","display_name":"carbamazepine-10,11-epoxide","score":0.9490000009536743},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9419999718666077},{"id":"https://openalex.org/keywords/epilepsy-treatment","display_name":"epilepsy treatment","score":0.5040000081062317},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.718999981880188},{"id":"https://openalex.org/keywords/liver-enzymes","display_name":"liver enzymes","score":0.5490000247955322}],"concepts":[{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.937529981136322},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.8340016603469849},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.7955201864242554},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6856127977371216},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6602314114570618},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5730849504470825},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.4918971061706543},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.44466063380241394},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42217332124710083},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.42080971598625183},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.4163685441017151},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39855366945266724},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15019631385803223},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.13764193654060364},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004032","descriptor_name":"Diet","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9893926","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9893926","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"Clinical Trial"},{"id":"mag:64455787","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9893926","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2465316286","https://openalex.org/W2398502506","https://openalex.org/W52917832","https://openalex.org/W4327484913","https://openalex.org/W2091096026","https://openalex.org/W784230264","https://openalex.org/W2005561977","https://openalex.org/W4283214066","https://openalex.org/W2234260592","https://openalex.org/W2053969120"],"abstract_inverted_index":{"Carbamazepine":[0],"(CAS":[1],"298-46-4),":[2],"an":[3,43],"iminostilbene":[4],"derivative":[5],"and":[6,117,140,148,157,186,281],"a":[7,29,39,61,96,101,124,155,204,222,235],"structural":[8],"congener":[9],"of":[10,21,28,64,98,105,138,146,169,184,198,206,224,238,247,283],"the":[11,19,67,84,87,112,173,188,217,245,248,268,274],"tricyclic":[12],"antidepressant":[13],"drugs,":[14],"has":[15],"been":[16],"used":[17],"in":[18,42,48,242],"treatment":[20,106,185],"epileptic":[22],"seizures":[23],"since":[24],"1963.":[25],"The":[26,164,194],"bioavailability/bioequivalence":[27],"carbamazepine":[30,139,147,170],"sustained":[31],"release":[32],"formulation":[33,41,89,270,276],"(Timonil":[34],"retard)":[35],"was":[36,70,90,177,252,265],"compared":[37],"with":[38,161,228,277],"reference":[40,88,275],"open":[44],"2-period":[45],"crossover":[46],"study":[47,256],"21":[49],"healthy":[50],"male":[51],"volunteers":[52],"(including":[53],"1":[54],"drop-out)":[55],"after":[56,182],"multiple":[57],"dose":[58,69],"administration.":[59],"During":[60,216],"run-in":[62],"phase":[63],"6":[65],"days":[66,79,104,115,181],"daily":[68],"gradually":[71],"increased":[72],"from":[73,254],"100":[74],"to":[75,81,109,230,234,273,279],"400":[76],"mg.":[77],"On":[78,111],"9":[80],"15,":[82],"either":[83],"test":[85,269],"or":[86],"administered":[91],"twice":[92],"daily,":[93],"followed":[94],"by":[95,203],"switch":[97],"preparation":[99],"for":[100,136,190],"further":[102,255],"7":[103],"(days":[107],"16":[108],"22).":[110],"pharmacokinetic":[113],"profiling":[114],"15":[116],"22":[118],"blood":[119,129],"samples":[120,130],"were":[121,131,152,192,201,259],"drawn":[122],"over":[123],"24-h":[125],"period.":[126],"In":[127],"addition,":[128],"withdrawn":[132],"before":[133],"morning":[134],"administrations":[135],"determination":[137],"carbamazepine-10,11-epoxide":[141,151],"trough":[142],"values.":[143],"Plasma":[144],"concentrations":[145],"its":[149],"metabolite":[150],"determined":[153],"using":[154],"specific":[156],"sensitive":[158],"HPLC":[159],"method":[160],"UV":[162],"detection.":[163],"results":[165],"showed":[166],"that":[167,187,267],"autoinduction":[168],"metabolism":[171],"under":[172],"chosen":[174],"dosage":[175],"regimen":[176],"complete":[178],"within":[179],"14":[180],"start":[183],"criteria":[189],"bioequivalence":[191],"met.":[193],"90%":[195],"confidence":[196],"intervals":[197],"all":[199],"ratios":[200],"included":[202],"range":[205],"80-125%":[207],"(AUC0-12:":[208],"103-120;":[209],"AUC12-24:":[210],"105-119;":[211],"Cmax0-12:":[212],"104-118;":[213],"Cmax12-24:":[214],"104-118).":[215],"study,":[218,249],"12":[219],"subjects":[220],"experienced":[221],"total":[223],"24":[225],"adverse":[226,262],"events":[227],"mild":[229],"moderate":[231],"intensity.":[232],"Due":[233],"significant":[236],"increase":[237],"liver":[239],"enzyme":[240],"activity":[241],"serum":[243],"during":[244],"course":[246],"one":[250],"subject":[251],"excluded":[253],"participation.":[257],"There":[258],"no":[260],"serious":[261],"events.":[263],"It":[264],"concluded":[266],"is":[271],"bioequivalent":[272],"respect":[278],"rate":[280],"extent":[282],"absorption.":[284]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}